Lilly says diabetes drug Trulicity reduces heart risks in trial

Eli Lilly and Co said on Monday that its top-selling diabetes drug Trulicity significantly reduced the risk of heart attack, stroke and heart-related death in a broad range of people with type 2 diabetes, according to results of a large clinical trial.

from Reuters: Health News https://ift.tt/2D3DQYI
via IFTTT